Cleared Traditional

K141050 - ENSITE VELOCITY SYSTEM

K141050 is an FDA 510(k) clearance for ENSITE VELOCITY SYSTEM, manufactured by St Jude Medical. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 44-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2014
Decision
44d
Days
Class 2
Risk

K141050 is an FDA 510(k) clearance for the ENSITE VELOCITY SYSTEM. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by St Jude Medical (St. Paul, US). The FDA issued a Cleared decision on June 6, 2014 after a review of 44 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all St Jude Medical devices

FDA 510(k) Submission Details - K141050

510(k) Number K141050 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 23, 2014
Decision Date June 06, 2014
Days to Decision 44 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
81d faster than avg
Panel avg: 125d · This submission: 44d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 373
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K141050.
ZEUS (ZIO ECG Utilization Service) System
K142681 · iRhythm Technologies, Inc. · Nov 2014
ECVUE MAPPING SYSTEM
K140497 · Cardioinsight Technologies, Inc. · Nov 2014
CARTO 3 EP NAVIGATION SYSTEM, VERSION 4.2
K133916 · Biosense Webster, Inc. · Jul 2014
V2.7 SOFTWARE FOR THE LABSYSTEM PRO EP RECORDING SYSTEM
K141185 · Boston Scientific Corp · Jun 2014
MCKESSON CARDIOLOGY ECG MOBILE
K133534 · Mckesson Israel , Ltd. · Apr 2014
EP-TRACER SYSTEM, EP-TRACER SYSTEM, EP-TRACER SYSTEM
K134044 · Cardio Tek, BV · Mar 2014